Detalhe da pesquisa
1.
Predictive factors for transition to conversion therapy in hepatocellular carcinoma using atezolizumab plus bevacizumab.
Liver Int
; 44(6): 1456-1463, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38488749
2.
Efficacy and safety of cold forceps biopsy for diminutive pharyngeal neoplasms: Single-center, prospective pilot study.
Dig Endosc
; 33(5): 761-769, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-32920920
3.
Response to the letter: "Predictive factors for transition to conversion therapy in HCC using atezolizumab plus bevacizumab".
Liver Int
; 2024 May 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38717049
4.
Impact of Nutritional Status on Neutrophil-to-Lymphocyte Ratio as a Predictor of Efficacy and Adverse Events of Immune Check-Point Inhibitors.
Cancers (Basel)
; 16(10)2024 May 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-38791890
5.
Clinical Outcomes of Next-Generation Microwave Thermosphere Ablation for Hepatocellular Carcinoma with Primarily Hepatitis-Related Etiology.
J Clin Med
; 12(24)2023 Dec 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38137645
6.
Characteristics of hepatocellular carcinoma in patients with hepatitis C virus who received direct-acting antiviral therapy and achieved sustained virological response: The impact of a hepatologist on surveillance.
JGH Open
; 6(7): 462-469, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35822120